- Home
- FRGE vs NLSP Comparison
FRGE vs NLSP Comparison
Compare FRGE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- NLSP
- Stock Information
- Founded
- FRGE 2014
- NLSP 2015
- Country
- FRGE United States
- NLSP Switzerland
- Employees
- FRGE N/A
- NLSP N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- NLSP Health Care
- Exchange
- FRGE Nasdaq
- NLSP Nasdaq
- Market Cap
- FRGE 256.4M
- NLSP 243.8M
- IPO Year
- FRGE N/A
- NLSP 2021
- Fundamental
- Price
- FRGE $1.18
- NLSP $4.90
- Analyst Decision
- FRGE Strong Buy
- NLSP
- Analyst Count
- FRGE 3
- NLSP 0
- Target Price
- FRGE $4.50
- NLSP N/A
- AVG Volume (30 Days)
- FRGE 280.9K
- NLSP 25.9K
- Earning Date
- FRGE 11-05-2024
- NLSP 10-11-2024
- Dividend Yield
- FRGE N/A
- NLSP N/A
- EPS Growth
- FRGE N/A
- NLSP N/A
- EPS
- FRGE N/A
- NLSP N/A
- Revenue
- FRGE $79,146,000.00
- NLSP N/A
- Revenue This Year
- FRGE $29.88
- NLSP N/A
- Revenue Next Year
- FRGE $40.03
- NLSP N/A
- P/E Ratio
- FRGE N/A
- NLSP N/A
- Revenue Growth
- FRGE 21.91
- NLSP N/A
- 52 Week Low
- FRGE $1.16
- NLSP $4.08
- 52 Week High
- FRGE $4.02
- NLSP $40.60
- Technical
- Relative Strength Index (RSI)
- FRGE 35.93
- NLSP 37.46
- Support Level
- FRGE $1.28
- NLSP $4.72
- Resistance Level
- FRGE $1.37
- NLSP $5.50
- Average True Range (ATR)
- FRGE 0.07
- NLSP 0.65
- MACD
- FRGE -0.01
- NLSP 0.02
- Stochastic Oscillator
- FRGE 8.33
- NLSP 28.47
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.